Medicare

What may sound like a legit phone call could lead to your Medicare benefits being stolen by scammers. NBC 5 Responds reporter Diana Zoga explains what you need to know to protect yourself.

The government spent nearly $950 billion on Medicare funding in 2022, according to the Centers for Medicare and Medicaid Services. According to some estimates, scammers claim around $60 billion of funds.

From Oct. 15 through Dec. 7, Medicare enrollees have the ability to switch plans for 2025. Here’s what changes experts say to watch for next year.

WellMed aims to change the face of health care delivery for the nation by providing quality, proactive patient care with a focus on prevention.

The negotiated price cuts won’t take effect until 2026, but a $2,000 annual cap on out-of-pocket prescription drug costs begins for all Medicare Part D enrollees next year.

The Biden administration announced Thursday that the prices of 10 popular, and expensive, drugs would be cut for Medicare Part D enrollees beginning January 2026.

The Biden administration is taking a victory lap after federal officials inked deals with drug companies to lower the price for 10 of Medicare’s most costliest drugs.

The vote, by the Ways and Means Committee, is one of the first steps needed to reverse a more than two decades-old ban prohibiting the government from paying for the drugs.

President Joe Biden often overstates what people who are eligible for the price cap for insulin paid previously.

Medicare’s recent move to cover the weight-loss drug Wegovy for some recipients with heart disease risk could drive up the cost of monthly premiums for many of the 65 million adults enrolled in the federal health insurance program.

UnitedHealthcare shares important information about Medicare Annual Enrollment and things to consider when picking a plan.

WellMed shares tips on things to consider during this years Medicare Open Enrollment.

WellMed uses proven, measurable, and results-driven health care to help provide better preventive care to older adults.

Judge Thomas Rose of the U.S. District Court for the Southern District of Ohio withdrew from a case that could block Medicare’s drug price negotiation program.

This is part of the Biden administration’s effort to lower drug prices by negotiating directly with the manufacturers.

The move is expected to cut costs for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers.

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.

Hundreds of thousands of Texans stand to lose healthcare coverage after federal changes to Medicaid. State leaders joined faith leaders to call on federal leaders to reverse a Centers for Medicare & Medicaid Services policy change.

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion.

Patients will have to participate in registries that collect real-world data on how the drug works as a condition of coverage.